Shabbir Rangwala

1 ta ish

Glenmark Pharmaceuticals (India)

1. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

   Zarir Udwadia, Pawan Singh, Hanmant Barkate +7

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.258242